BackBriaCell Therapeutics Overview

BriaCell Therapeutics EBIT

EBIT (Earnings Before Interest and Taxes) analysis for BCTX.

Quarterly EBIT

-$7.68M
↓ 24.19% YoY

As of Apr 30, 2026

Annual EBIT (TTM)

-$26.11M
↓ 7.53% YoY

Trailing 12 months ending Apr 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin